Skip to main content
Erschienen in: Head and Neck Pathology 2/2016

06.10.2015 | Original Paper

Epithelial–Mesenchymal Transition Protein Expression in Basal Cell Adenomas and Basal Cell Adenocarcinomas

verfasst von: Brennan A. Tesdahl, Thomas C. Wilson, Henry T. Hoffman, Robert A. Robinson

Erschienen in: Head and Neck Pathology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Basal cell adenomas and basal cell adenocarcinomas show marked histomorphologic similarity and are separated microscopically primarily by the invasive characteristics of the adenocarcinomas. We wished to explore potential differences in the expression of epithelial–mesenchymal transition associated proteins in these two tumor types. A tissue microarray was constructed utilizing 29 basal cell adenomas and 16 basal cell adenocarcinomas. Immunohistochemical expression of E-cadherin, beta-catenin, Twist 1 and vimentin were investigated. Both tumors expressed all proteins in a relatively similar manner. Nuclear beta-catenin was essentially limited to the abluminal cell populations in both tumor types. E-cadherin was limited largely to luminal locations but was more prevalent in the adenocarcinomas as compared to the adenomas. Primarily abluminal expression for vimentin was seen, sometimes present in an apical dot-like pattern. Distinct populations of cellular expression of these four markers of epithelial mesenchymal transition were present but were similar in locations in both tumors with no patterns discerned to separate basal cell adenoma from basal cell adenocarcinoma. Given these findings, the mechanisms by which basal cell adenocarcinoma is able to invade while its counterpart, basal cell adenoma can not, may be more complex than in other tumor types.
Literatur
1.
Zurück zum Zitat Wilson T, Robinson RA. Basal cell adenoma and basal cell adenocarcinoma of the salivary glands: a clinicopathological of seventy tumors with comparison of morphologic features and growth control indices. Head Neck Pathol. 2015;9(2):205–13.CrossRefPubMedPubMedCentral Wilson T, Robinson RA. Basal cell adenoma and basal cell adenocarcinoma of the salivary glands: a clinicopathological of seventy tumors with comparison of morphologic features and growth control indices. Head Neck Pathol. 2015;9(2):205–13.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 2005;233(3):706–20.CrossRefPubMed Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 2005;233(3):706–20.CrossRefPubMed
3.
Zurück zum Zitat Montgomery E, Folpe AL. The diagnostic value of beta-catenin immunohistochemistry. Adv Anat Pathol. 2005;12(6):350–6.CrossRefPubMed Montgomery E, Folpe AL. The diagnostic value of beta-catenin immunohistochemistry. Adv Anat Pathol. 2005;12(6):350–6.CrossRefPubMed
4.
5.
Zurück zum Zitat Nijkamp MM, Span PN, Hoogsteen IJ, van der Kogel AJ, Kaanders JH, Bussink J. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol. 2011;99(3):344–8.CrossRefPubMed Nijkamp MM, Span PN, Hoogsteen IJ, van der Kogel AJ, Kaanders JH, Bussink J. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol. 2011;99(3):344–8.CrossRefPubMed
6.
7.
Zurück zum Zitat Economopoulou P, Hanby A, Odell EW. Expression of E-cadherin, cellular differentiation and polarity in epithelial salivary neoplasms. Oral Oncol. 2000;36(6):515–8.CrossRefPubMed Economopoulou P, Hanby A, Odell EW. Expression of E-cadherin, cellular differentiation and polarity in epithelial salivary neoplasms. Oral Oncol. 2000;36(6):515–8.CrossRefPubMed
8.
Zurück zum Zitat Furuse C, Cury PR, Altemani A, dos Santos Pintos D Jr, de Araujo NS, de Araujo VC. Beta-catenin and E-cadherin expression in salivary gland tumors. Int J Surg Pathol. 2006;12(3):212–7.CrossRef Furuse C, Cury PR, Altemani A, dos Santos Pintos D Jr, de Araujo NS, de Araujo VC. Beta-catenin and E-cadherin expression in salivary gland tumors. Int J Surg Pathol. 2006;12(3):212–7.CrossRef
9.
Zurück zum Zitat Andreadis D, Epivatianos A, Mireas G, et al. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours. J Laryngol Otol. 2006;120(4):298–304.CrossRefPubMed Andreadis D, Epivatianos A, Mireas G, et al. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours. J Laryngol Otol. 2006;120(4):298–304.CrossRefPubMed
10.
Zurück zum Zitat Prabhu S, Kaveri H, Rekha K. Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin. Oral Oncol. 2009;45(7):594–9.CrossRefPubMed Prabhu S, Kaveri H, Rekha K. Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin. Oral Oncol. 2009;45(7):594–9.CrossRefPubMed
11.
Zurück zum Zitat Toshitaka N. Immunohistochemical analysis of salivary gland tumors: applications for surgical pathology practice. Acta Histochem Cytochem. 2012;45(5):269–82.CrossRef Toshitaka N. Immunohistochemical analysis of salivary gland tumors: applications for surgical pathology practice. Acta Histochem Cytochem. 2012;45(5):269–82.CrossRef
12.
Zurück zum Zitat Kawahara A, Harada H, Abe H, Yamaguchi T, Taira T, Nakashima K, et al. Nuclear B-catenin expression in basal cell adenomas of salivary gland. J Oral Pathol Med. 2011;40(6):460–6.CrossRefPubMed Kawahara A, Harada H, Abe H, Yamaguchi T, Taira T, Nakashima K, et al. Nuclear B-catenin expression in basal cell adenomas of salivary gland. J Oral Pathol Med. 2011;40(6):460–6.CrossRefPubMed
13.
Zurück zum Zitat Chandrashekar C, Angadi PV, Krishnapillai R. B-catenin expression in benign and malignant salivary gland tumors. Int J Surg Pathol. 2011;19(4):433–40.CrossRefPubMed Chandrashekar C, Angadi PV, Krishnapillai R. B-catenin expression in benign and malignant salivary gland tumors. Int J Surg Pathol. 2011;19(4):433–40.CrossRefPubMed
14.
Zurück zum Zitat Mantesso A, Loducca SV, Jaeger RG, Decio SP, Araujo VC. Analysis of epithelial–myoepithelial carcinoma based on the establishment of a novel cell line. Oral Oncol. 2003;39:453–8.CrossRefPubMed Mantesso A, Loducca SV, Jaeger RG, Decio SP, Araujo VC. Analysis of epithelial–myoepithelial carcinoma based on the establishment of a novel cell line. Oral Oncol. 2003;39:453–8.CrossRefPubMed
15.
Zurück zum Zitat Lill C, Schneider S, Seemann R, Kadletz L, Aumayr K, Ghanim B, et al. Correlation of B-catenin, but not PIN1 and cyclin D1, overexpression with disease-free and overall survival in patients with cancer of the parotid gland. Head Neck. 2015;37(1):30–6.CrossRefPubMed Lill C, Schneider S, Seemann R, Kadletz L, Aumayr K, Ghanim B, et al. Correlation of B-catenin, but not PIN1 and cyclin D1, overexpression with disease-free and overall survival in patients with cancer of the parotid gland. Head Neck. 2015;37(1):30–6.CrossRefPubMed
16.
Zurück zum Zitat Shieh YS, Change LC, Chiu KC, Wu CW, Lee HS. Cadherin and catenin expression in mucoepidermoid carcinoma: correlation with histopathologic grade, clinical stage and patient outcome. J Oral Pathol Med. 2003;32(5):297–304.CrossRefPubMed Shieh YS, Change LC, Chiu KC, Wu CW, Lee HS. Cadherin and catenin expression in mucoepidermoid carcinoma: correlation with histopathologic grade, clinical stage and patient outcome. J Oral Pathol Med. 2003;32(5):297–304.CrossRefPubMed
17.
Zurück zum Zitat Ansieau S, Bastid J, Doreau A, Morel A-P, Bouchet BP, Thomas C, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 2008;14:79–89.CrossRefPubMed Ansieau S, Bastid J, Doreau A, Morel A-P, Bouchet BP, Thomas C, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 2008;14:79–89.CrossRefPubMed
18.
Zurück zum Zitat Zhou C, Liu J, Tang Y, Zhu G, Zheng M, Jiang J, et al. Coexpression of hypoxia-inducible factor-2α, TWIST2, and SIP1 may correlate with invasion and metastasis of salivary adenoid cystic carcinoma. J Oral Pathol Med. 2012;41(5):424–31.CrossRefPubMed Zhou C, Liu J, Tang Y, Zhu G, Zheng M, Jiang J, et al. Coexpression of hypoxia-inducible factor-2α, TWIST2, and SIP1 may correlate with invasion and metastasis of salivary adenoid cystic carcinoma. J Oral Pathol Med. 2012;41(5):424–31.CrossRefPubMed
19.
Zurück zum Zitat Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117:927–39.CrossRefPubMed Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117:927–39.CrossRefPubMed
20.
Zurück zum Zitat Vesuna F, van Diest P, Chen JH, Raman V. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun. 2008;367(2):235–41.CrossRefPubMedPubMedCentral Vesuna F, van Diest P, Chen JH, Raman V. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun. 2008;367(2):235–41.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kidd ME, Shumaker DK, Ridge KM. The role of vimentin intermediate filaments in the progression of lung cancer. Am J Respir Cell Mol Biol. 2014;50(1):1–6.PubMedPubMedCentral Kidd ME, Shumaker DK, Ridge KM. The role of vimentin intermediate filaments in the progression of lung cancer. Am J Respir Cell Mol Biol. 2014;50(1):1–6.PubMedPubMedCentral
Metadaten
Titel
Epithelial–Mesenchymal Transition Protein Expression in Basal Cell Adenomas and Basal Cell Adenocarcinomas
verfasst von
Brennan A. Tesdahl
Thomas C. Wilson
Henry T. Hoffman
Robert A. Robinson
Publikationsdatum
06.10.2015
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 2/2016
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-015-0657-6

Weitere Artikel der Ausgabe 2/2016

Head and Neck Pathology 2/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …